masteruz hat einige % verdient, ist mal wieder ein zeichen dafür das man in der heutigen zeit nu wirklich auf irgendwelche Analysten verzichten kann oder? Also muß man auch nicht wissen wann diese von einem Unternehmen unterichtet werden, wie es um das besagte Unternehmen steht.
Na gut ich setz es trozdem mal rein,alles gute weiterhin
gruß grenke
Calypte Biomedical to Present at the Wall Street Analyst Forum 47Th Annual Institutional Investor Conference
ALAMEDA, Calif., Feb 5, 2003 (BUSINESS WIRE) -- Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot supplemental test, today announced that it will be presenting at the Wall Street Analyst Forum 47th Institutional Investor Conference at The Roosevelt Hotel in New York City, New York on Monday, February 10, 2003 at 9:00 a.m. ET.
Presenting for Calypte will be Tony Cataldo, chairman and Nancy Katz, president and CEO. The webcast presentation will also be broadcast over the Internet. To listen to the presentation, please go to the investor's section of Calypte's web site at www.calypte.com and register for the webcast presentation. An archived replay will be available after the conclusion of the presentation for 30 days.
About Calypte Biomedical:
Calypte Biomedical Corporation headquartered in Alameda, California, is a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services for Human Immunodeficiency Virus Type 1 (HIV-1), sexually transmitted diseases and other infectious diseases. Calypte's tests include the screening EIA and supplemental Western Blot tests, the only two FDA-approved HIV-1 antibody tests that can be used on urine samples. The company believes that accurate, non-invasive urine-based testing methods for HIV and other infectious diseases may make important contributions to public health by helping to foster an environment in which testing may be done safely, economically, and painlessly. Calypte markets its products in countries worldwide through international distributors and strategic partners. Current product labeling including specific product performance claims can be found on our website at www.calypte.com.
CONTACT: Calypte Biomedical Corporation
Nancy Katz, 510/749-5100
nkatz@calypte.com
or
Lippert/Heilshorn & Associates
Brendan Lahiff/Kirsten Chapman, 415/433-3777 (IR)
brendan@lhai-sf.com
URL: www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2003 Business Wire. All rights reserved.